Patents by Inventor David RAISER

David RAISER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260102512
    Abstract: Disclosed herein are compositions and methods related to megakaryocyte-derived extracellular vesicles derived from human pluripotent stem cells, where the megakaryocyte-derived extracellular vesicles may be utilized for treating Fanconi anemia (FA).
    Type: Application
    Filed: December 5, 2025
    Publication date: April 16, 2026
    Inventors: Jonathan THON, David RAISER, Laura GOLDBERG
  • Patent number: 12521449
    Abstract: Disclosed herein are compositions and methods related to megakaryocyte-derived extracellular vesicles derived from human pluripotent stem cells, where the megakaryocyte-derived extracellular vesicles may be utilized for treating Fanconi anemia (FA).
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: January 13, 2026
    Assignee: STRM.bio Incorporated
    Inventors: Jonathan Thon, David Raiser, Laura Goldberg
  • Publication number: 20250057888
    Abstract: Various aspects described herein provide methods of generating alveolar or alveolar/airway organoids from a population of lung cells to differentiate into alveolar or alveolar/airway organoids. Also provided herein are methods and compositions for treating lung disease comprising transplantation of the alveolar or alveolar/airway organoids, or a cell isolated therefrom to a subject.
    Type: Application
    Filed: September 13, 2024
    Publication date: February 20, 2025
    Inventors: Carla F. KIM, Sharon M. LOUIE, Erhan ARARAT, David RAISER
  • Patent number: 12109242
    Abstract: Various aspects described herein provide methods of generating alveolar or alveolar/airway organoids from a population of lung cells to differentiate into alveolar or alveolar/airway organoids. Also provided herein are methods and compositions for treating lung disease comprising transplantation of the alveolar or alveolar/airway organoids, or a cell isolated therefrom to a subject.
    Type: Grant
    Filed: October 19, 2020
    Date of Patent: October 8, 2024
    Inventors: Carla F. Kim, Sharon M. Louie, Erhan Ararat, David Raiser
  • Publication number: 20240216532
    Abstract: Disclosed herein are compositions and methods related to megakaryocyte-derived extracellular vesicles derived from human pluripotent stem cells, where the megakaryocyte-derived extracellular vesicles may be utilized for treating Fanconi anemia (FA).
    Type: Application
    Filed: April 26, 2022
    Publication date: July 4, 2024
    Inventors: Jonathan THON, David RAISER, Laura GOLDBERG
  • Publication number: 20210030811
    Abstract: Various aspects described herein provide methods of generating alveolar or alveolar/airway organoids from a population of lung cells to differentiate into alveolar or alveolar/airway organoids. Also provided herein are methods and compositions for treating lung disease comprising transplantation of the alveolar or alveolar/airway organoids, or a cell isolated therefrom to a subject.
    Type: Application
    Filed: October 19, 2020
    Publication date: February 4, 2021
    Applicant: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Carla F. KIM, Sharon M. LOUIE, Erhan ARARAT, David RAISER